E B Mallow1, M A Fox1. 1. Johns Hopkins Bloomberg School of Public Health, Risk Sciences and Public Policy Institute, Baltimore, MD, USA.
Abstract
OBJECTIVE: To assess the types and magnitudes of non-endocrine toxic risks to neonates associated with medical device-related exposures to di(2-ethylhexyl)phthalate (DEHP). STUDY DESIGN: Dose-response thresholds for DEHP toxicities were determined from published data, as were the magnitudes of DEHP exposures resulting from neonatal contact with polyvinyl chloride (PVC) devices. Standard methods of risk assessment were used to determine safe levels of DEHP exposure in neonates, and hazard quotients were calculated for devices individually and in aggregate. RESULT: Daily intake of DEHP for critically ill preterm infants can reach 16 mg/kg per day, which is on the order of 4000 and 160,000 times higher than desired to avoid reproductive and hepatic toxicities, respectively. The non-endocrine toxicities of DEHP are similar to complications experienced by preterm neonates. CONCLUSION: DEHP exposures in neonatal intensive care are much higher than estimated safe limits, and might contribute to common early and chronic complications of prematurity. Concerns about phthalates should be expanded beyond endocrine disruption.
OBJECTIVE: To assess the types and magnitudes of non-endocrine toxic risks to neonates associated with medical device-related exposures to di(2-ethylhexyl)phthalate (DEHP). STUDY DESIGN: Dose-response thresholds for DEHPtoxicities were determined from published data, as were the magnitudes of DEHP exposures resulting from neonatal contact with polyvinyl chloride (PVC) devices. Standard methods of risk assessment were used to determine safe levels of DEHP exposure in neonates, and hazard quotients were calculated for devices individually and in aggregate. RESULT: Daily intake of DEHP for critically ill preterm infants can reach 16 mg/kg per day, which is on the order of 4000 and 160,000 times higher than desired to avoid reproductive and hepatic toxicities, respectively. The non-endocrine toxicities of DEHP are similar to complications experienced by preterm neonates. CONCLUSION:DEHP exposures in neonatal intensive care are much higher than estimated safe limits, and might contribute to common early and chronic complications of prematurity. Concerns about phthalates should be expanded beyond endocrine disruption.
Authors: Leonard T Rael; Raphael Bar-Or; Daniel R Ambruso; Charles W Mains; Denetta S Slone; Michael L Craun; David Bar-Or Journal: Oxid Med Cell Longev Date: 2009 Jul-Aug Impact factor: 6.543
Authors: Jennifer Weuve; Brisa N Sánchez; Antonia M Calafat; Ted Schettler; Ronald A Green; Howard Hu; Russ Hauser Journal: Environ Health Perspect Date: 2006-09 Impact factor: 9.031
Authors: Annemarie Stroustrup; Jennifer B Bragg; Stefanie A Busgang; Syam S Andra; Paul Curtin; Emily A Spear; Allan C Just; Manish Arora; Chris Gennings Journal: J Expo Sci Environ Epidemiol Date: 2018-09-21 Impact factor: 5.563
Authors: Luísa Camacho; John R Latendresse; Levan Muskhelishvili; Charles D Law; K Barry Delclos Journal: Food Chem Toxicol Date: 2020-06-13 Impact factor: 6.023
Authors: Abby G Wenzel; Jessica L Reiner; Satomi Kohno; Bethany J Wolf; John W Brock; Lori Cruze; Roger B Newman; John R Kucklick Journal: Chemosphere Date: 2020-09-18 Impact factor: 8.943
Authors: J William Gaynor; Richard F Ittenbach; Antonia M Calafat; Nancy B Burnham; Asa Bradman; David C Bellinger; Frederick M Henretig; Erin E Wehrung; J Laurenson Ward; William W Russell; Thomas L Spray Journal: Ann Thorac Surg Date: 2018-07-30 Impact factor: 5.102